Title: Allogeneic Transplantation for the Treatment of Multiple Myeloma
Abstract:Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells. The annual incidence is four per 100,000 individuals. It was estimated that 19,900 new cases wou...Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells. The annual incidence is four per 100,000 individuals. It was estimated that 19,900 new cases would be diagnosed in 2007, with 10,790 estimated deaths due to myeloma [1]. The median age at diagnosis is approximately 65 years, making it a disease that predominantly affects older patients. Although myeloma cells are chemosensitive, the median survival for patients with multiple myeloma remains less than 5 years.Read More
Publication Year: 2009
Publication Date: 2009-11-27
Language: en
Type: book-chapter
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot